Literature DB >> 19140362

Neurological complications of chronic myeloid leukaemia: any cure?

D E Joseph1, J D Emmanuel, M A Durosinmi, M A Dorusinmi.   

Abstract

OBJECTIVE: To attempt to explain the non-reversal, contrary to the widely held view, of the neurological deficits complicating chronic myeloid leukaemia.
METHOD: Using patients' case folders and haematological malignancy register all cases of chronic myeloid leukaemia seen in Jos University Teaching Hospital between July 1995 and June 2005 were retrospectively studied. All the available literature on the subject was also reviewed.
RESULTS: Thirty-three cases of chronic myeloid leukaemia were seen within the study period. Five (15.15%) of them had one or more sensori-neural defects. Of the five, two (40%) patients presented with bilateral hearing impairment, each beginning with the left ear; one (20%) presented with left ear hearing loss; one (20%) came with severe left ear tinnitus; one (20%) presented with complete bilateral hearing and bilateral visual losses. Fundoscopy showed leukaemic deposits on the retina. Other causes of blindness and deafness, e.g. trauma and foreign body in the ear respectively, were excluded.
CONCLUSION: While the complications due to hyperleucocytosis-induced stasis recover following the conventional treatment, those due to other pathogenetic mechanisms such as leukaemic deposits do not return to their pre-morbid states following disease control despite the use of the currently available treatment protocols. For future research, more still needs to be done to elicit other uncommon pathogenetic mechanisms underlying these complications with a view to finding specific treatment measures for worrisome chronic myeloid leukaemia-related sensori-neural deficits.

Entities:  

Mesh:

Year:  2008        PMID: 19140362

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  3 in total

1.  Chronic myeloid leukemia presenting with visual and auditory impairment in an adolescent: an insight to management strategies.

Authors:  Muge Gokce; Sule Unal; Benan Bayrakçı; Murat Tuncer
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-01       Impact factor: 0.900

2.  Myeloid Sarcoma of Temporal Bone: A Rare Manifestation of Relapse Acute Myeloid Leukemia.

Authors:  Bee See Goh; Chian Ling Tang; Geok Chin Tan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-12-12

3.  Permanent sensorineural deafness in a patient with chronic myelogenous leukemia secondary to intracranial hemorrhage.

Authors:  Sakshi Kapur; Michael Wax; Levin Miles; Adnan Hussain
Journal:  Case Rep Hematol       Date:  2013-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.